To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.
Identifieur interne : 001915 ( Main/Corpus ); précédent : 001914; suivant : 001916To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.
Auteurs : Konstantinos ParperisSource :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2021.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Antimalarials.
- prevention & control : Pandemics.
- COVID-19, Humans, Hydroxychloroquine, SARS-CoV-2.
DOI: 10.1136/annrheumdis-2020-217557
PubMed: 32321722
Links to Exploration step
pubmed:32321722Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.</title>
<author><name sortKey="Parperis, Konstantinos" sort="Parperis, Konstantinos" uniqKey="Parperis K" first="Konstantinos" last="Parperis">Konstantinos Parperis</name>
<affiliation><nlm:affiliation>Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus kparpe02@ucy.ac.cy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:32321722</idno>
<idno type="pmid">32321722</idno>
<idno type="doi">10.1136/annrheumdis-2020-217557</idno>
<idno type="wicri:Area/Main/Corpus">001915</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001915</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.</title>
<author><name sortKey="Parperis, Konstantinos" sort="Parperis, Konstantinos" uniqKey="Parperis K" first="Konstantinos" last="Parperis">Konstantinos Parperis</name>
<affiliation><nlm:affiliation>Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus kparpe02@ucy.ac.cy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (therapeutic use)</term>
<term>COVID-19 (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32321722</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>80</Volume>
<Issue>1</Issue>
<PubDate><Year>2021</Year>
<Month>01</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.</ArticleTitle>
<Pagination><MedlinePgn>e8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217557</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parperis</LastName>
<ForeName>Konstantinos</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">0000-0001-6009-0130</Identifier>
<AffiliationInfo><Affiliation>Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus kparpe02@ucy.ac.cy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Ann Rheum Dis. 2020 May;79(5):666-667</RefSource>
<PMID Version="1">32241791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Ann Rheum Dis. 2021 Jan;80(1):e9</RefSource>
<PMID Version="1">32366521</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="Y">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">arthritis</Keyword>
<Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">lupus erythematosus</Keyword>
<Keyword MajorTopicYN="Y">rheumatoid</Keyword>
<Keyword MajorTopicYN="Y">systemic</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32321722</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-217557</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-217557</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001915 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001915 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32321722 |texte= To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32321722" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |